Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell

NCT00518934 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Ischemia

Interventions

OTHER: Study for safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cell

Sponsor

Samsung Medical Center